This Challenge is based on the following scenario which has previously been reviewed and commented on in My GCP Zone. Please read the scenario before attempting the questions:

CRA Prioritising Exercise

You are the CRA on a global phase II clinical trial. You are CRA for all 4 sites in a single country and have just started on the project, taking over from a previous CRA who has just left the company. Prior to performing your first monitoring visits for the trial you review the Sponsor TMF for your country and notice the following:

Site 1 - there is no documented evidence that there has been an ethics committee approval for the site to perform the study. The site is actively enrolling and randomising patients into the trial.

Site 2 - there is no site selection visit report and no initiation visit report in the file even though the site has enrolled 14 patients into the trial.

Site 3 - While reviewing a report about data queries provided by Data Management this site appears to have virtually no data queries raised against the data but has the highest number of subjects recruited compared to all other sites

Site 4 - The TMF looks ok for this site although it is evident that there are considerably less screening failures at this site compared to other sites.

 

Challenge: CRA Priority Scenario
Question Number 1
From an ethical and subject safety perspective which site should be prioritised by the CRA to make contact with first?
A
Site 1
B
Site 2
C
Site 3
D
Site 4

PharmaSchool Logins

Learning Management Centre
CPMC Login
My GCP Zone Login
Retrieve Online Order

Free GCP & Regulatory Updates

PharmaSchool Online Courses:
Click here for the full range of Online GCP, Clinical Research and Development Courses from PharmaSchool.
Users in the following countries:
ALBANIA ANDORRA ANGOLA ARGENTINA ARMENIA AUSTRALIA AUSTRIA AZERBAIJAN BAHRAIN BANGLADESH BARBADOS BELARUS BELGIUM BELIZE BENIN BERMUDA BHUTAN BOSNIA AND HERZEGOVINA BOTSWANA BRAZIL BRUNEI DARUSSALAM BULGARIA BURKINA FASO BURUNDI CAMEROON CANADA CHILE CHINA COLOMBIA CROATIA CZECH REPUBLIC DENMARK DOMINICAN REPUBLIC ECUADOR EGYPT ETHIOPIA FINLAND FRANCE GAMBIA GEORGIA GERMANY GHANA GREECE HAITI HONDURAS HONG KONG HUNGARY ICELAND INDIA INDONESIA IRAN, ISLAMIC REPUBLIC OF IRELAND ISRAEL ITALY JAPAN JORDAN KENYA KUWAIT LEBANON LITHUANIA LUXEMBOURG MACEDONIA, THE FORMER YUGOSLAV REPUBLIC OF MALAWI MALAYSIA MALI MEXICO MOLDOVA, REPUBLIC OF NEPAL NETHERLANDS NEW ZEALAND NIGERIA NORWAY PAKISTAN PANAMA PERU PHILIPPINES POLAND PORTUGAL PUERTO RICO QATAR ROMANIA RUSSIAN FEDERATION RWANDA SAO TOME AND PRINCIPE SAUDI ARABIA SENEGAL SERBIA SINGAPORE SLOVAKIA SLOVENIA SOUTH AFRICA SPAIN SRI LANKA SUDAN SWEDEN SWITZERLAND TAIWAN, PROVINCE OF CHINA TANZANIA, UNITED REPUBLIC OF THAILAND TURKEY UKRAINE UNITED ARAB EMIRATES UNITED KINGDOM UNITED STATES UZBEKISTAN VANUATU VIET NAM ZAMBIA ZIMBABWE
 
 
Courses
Resources
News & Corporate Information